Back to Search
NADINE HYLTON, MD
MD
Obstetrics & Gynecology Physician
NPI: 1326156183Individual
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
C1-0008153(DE)R0480(TX)
Research & Publications (20)
Magnetic resonance imaging for secondary assessment of breast density in a high-risk cohort.
PMID 19631485·Magn Reson Imaging·2010
8-other
I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy.
PMID 19440188·Clin Pharmacol Ther·2009
4-observational
MRI methods for evaluating the effects of tyrosine kinase inhibitor administration used to enhance chemotherapy efficiency in a breast tumor xenograft model.
PMID 19388114·J Magn Reson Imaging·2009
7-preclinical
Ductal carcinoma in situ: state of the science and roadmap to advance the field.
PMID 19064970·J Clin Oncol·2009
6-review
Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging.
PMID 18566170·Radiology·2008
8-other
Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy.
PMID 18492917·AJR Am J Roentgenol·2008
3-trial
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
PMID 18258988·J Clin Oncol·2008
6-review
Improved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapy.
PMID 17968965·J Magn Reson Imaging·2007
7-preclinical
Kinetic assessment of breast tumors using high spatial resolution signal enhancement ratio (SER) imaging.
PMID 17685424·Magn Reson Med·2007
7-preclinical
AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
PMID 17371720·Magn Reson Imaging·2007
7-preclinical
Characterization of breast lesions using the 3D FIESTA sequence and contrast-enhanced magnetic resonance imaging.
PMID 17173311·J Magn Reson Imaging·2007
8-other
MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy.
PMID 17098179·Magn Reson Imaging Clin N Am·2006
6-review
Magnetic resonance imaging captures the biology of ductal carcinoma in situ.
PMID 17008702·J Clin Oncol·2006
8-other
Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal carcinoma in situ.
PMID 16978965·Am J Surg·2006
8-other
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
PMID 16829653·J Clin Oncol·2006
6-review
Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
PMID 16373758·Radiology·2006
4-observational
MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883.
PMID 16180227·J Surg Oncol·2005
3-trial
Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial.
PMID 16180217·J Surg Oncol·2005
3-trial
Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: assessment by voxel analysis of dynamic contrast-enhanced MRI.
PMID 16161072·J Magn Reson Imaging·2005
7-preclinical
MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival.
PMID 15908529·AJR Am J Roentgenol·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 6651 MAIN ST, SUITE 1020
HOUSTON, TX 77030 - Phone
- (832) 826-7458
Quick Facts
- NPI
- 1326156183
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile